Cover Image
Market Research Report

U.S. Market for Orthopedic Biomaterials

Published by iData Research Inc. Product code 239911
Published Content info 192 Pages
Delivery time: 1-2 business days
Back to Top
U.S. Market for Orthopedic Biomaterials
Published: August 1, 2013 Content info: 192 Pages
In 2012, the U.S. market for orthopedic biomaterials was valued at almost $3.4 billion with tremendous potential to grow. This total comprises eight different market segments. To find out more, please request a Sample.

The orthopedic biomaterials market has undergone a shift away from certain devices and towards new areas and medical devices. There is still tremendous potential for growth, especially in the younger market segments such as stem cells and concentration systems. Conversely, some products that previously experienced rapid market growth have now entered maturity, but even these markets are sustained by continued product evolution.

Scope : This report pertains to a forecast period of 10 years (2009 - 2019) for the U.S.

Report Contents:

  • Competitor Analysis
  • Identified Strategic Opportunities
  • Market Overview by Segment & Country
  • Trend Analysis by Segment & Country
  • Market Drivers & Limiters
  • Mergers & Acquisitions
  • Customer Feedback and Market Monitoring

Main Segments Included:

  • Orthopedic Bone Graft Substitute
  • Orthopedic Growth Factor
  • Orthopedic Stem Cell
  • Orthopedic Cell Therapy
  • Orthopedic Hyaluronic Acid Viscosupplementation
  • Orthopedic Tendon Graft
  • Orthopedic Cartilage Repair
  • Spinal Machined Bone Allograft

Sub-Segments Included:

  • Autograft
  • Standard Allograft
  • Demineralized Bone Matrix
  • Synthetic Bone Graft
  • Xenograft
  • BMP-2
  • BMP-7
  • Human Embryonic Stem Cells
  • Mesengchymal Stem Cells
  • Lumbar Spine Stem Cells
  • Cervical Spine Stem Cells
  • Platelet-Rich Plasma
  • Orthopedic Concentrated Bone Marrow Aspirate
  • Single-Injection
  • Three-Injection Cycle
  • Three/Five-Injection Cycle
  • BTB Graft
  • Soft Tissue Grafts
  • Ligament and Tendon Synthetic Graft
  • Osteochondral Allograft
  • Autologous Chondrocyte Implantation
  • Meniscal Allograft Tansplantation
  • ALIF Machined Bone Allograft
  • PLIF Machined Bone Allograft
  • TLIF Machined Bone Allograft
  • CIF Machined Bone Allograft

Companies Included:

  • Sanofi-Aventis/Genzyme
  • Bioventus
  • DePuy Synthes
  • Medtronic
  • Musculoskeletal Transplant Foundation
  • Stryker
  • RTI Biologics
  • NuVasive
  • Orthofix
  • LifeNet Health
  • AlloSource
  • Integra LifeSciences
  • Anika Therapeutics
  • Biomet
  • Ferring Pharmaceuticals
  • Exactech
  • Baxter
  • Harvest Technologies
  • Cytomedix
  • Wright Medical
  • Community Tissue Services
  • Olympus Biotech
  • Fidia
  • Arteriocyte
  • Alphatec Spine
  • Joint Restoration Foundation
  • University of Miami Tissue Bank
  • Celling Biosciences
  • Zimmer

Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our "ground up" approach, which includes primary and secondary research methods.

Back to Top